News

Forschungs-Update zum Welt-Multiple-Sklerose-Tag Forscher*innen widmen sich „verborgenen“ Symptomen der MS

Lexogen gains ISO 9001:2015 quality management certification

27 MAY 2021 POSITIVE PHASE 1 RESULTS WITH IMMUNOTHERAPIES TARGETING PCSK9 TO TREAT HYPERCHOLESTEROLEMIA PUBLISHED BY THE EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Marinomed Biotech AG Reports Financial Results for 1st Quarter 2021: Growth in Sales, due to persistent strong demand in Carragelose-based virus blockers

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform